- Open Access
Research recommendations to better understand the potential health impacts of microplastics to humans and aquatic ecosystems
Microplastics and Nanoplastics volume 2, Article number: 18 (2022)
To assess the potential risk of microplastic exposure to humans and aquatic ecosystems, reliable toxicity data is needed. This includes a more complete foundational understanding of microplastic toxicity and better characterization of the hazards they may present. To expand this understanding, an international group of experts was convened in 2020–2021 to identify critical thresholds at which microplastics found in drinking and ambient waters present a health risk to humans and aquatic organisms. However, their findings were limited by notable data gaps in the literature. Here, we identify those shortcomings and describe four categories of research recommendations needed to address them: 1) adequate particle characterization and selection for toxicity testing; 2) appropriate experimental study designs that allow for the derivation of dose-response curves; 3) establishment of adverse outcome pathways for microplastics; and 4) a clearer understanding of microplastic exposure, particularly for human health. By addressing these four data gaps, researchers will gain a better understanding of the key drivers of microplastic toxicity and the concentrations at which adverse effects may occur, allowing a better understanding of the potential risk that microplastics exposure might pose to human and aquatic ecosystems.
Researchers are finding microplastics almost everywhere they look. Microplastics, defined as solid, polymeric particles with at least three dimensions greater than 1 nm and < 5 mm in size , contaminate marine , freshwater , and terrestrial  habitats, and more recently, have been detected in drinking water [69, 102], food , and the atmosphere [13, 135]. Given their ubiquity, most organisms, including humans, are frequently exposed to microplastics. Studies in aquatic organisms show that microplastics can cause inflammation and tissue damage [63, 87], reduced growth , altered development , and reductions in reproductive success [26, 57]. Though the possible effects in humans are less well-defined, initial studies in rodent models suggest that exposure to some forms of microplastics may impact endocrine signaling [2, 3, 54], initiate oxidative stress and inflammation [77, 136, 141], and reduce gamete viability [4, 54, 80].
These findings have captured the attention of the public and increased societal concern for ecosystem and human health, prompting legislators, environmental managers, and other organizations to take action to better understand the risks of microplastic exposure. Within the past decade, the United Kingdom Parliament, the European Chemicals Agency, the European Food Safety Authority, and the World Health Organization have all released comprehensive reports and specific recommendations to assess the impact and potential risks of plastic and microplastic pollution [33, 37, 44, 100, 132]. Effective management of microplastics requires an understanding of the potential adverse health effects on humans and the environment, as well as the key drivers of toxicity (e.g., particle size, composition, etc.) and concentration thresholds at which these effects begin to manifest. However, developing health-based thresholds for microplastics is challenging because they represent a diverse suite of physical and chemical characteristics . Toxicological effects may be initiated via a variety of mechanisms rather than a single molecular initiating event, and some of these mechanisms are poorly elucidated. In support of legislative mandates to develop microplastics management strategies for aquatic habitats and drinking water for human consumption [146, 147], the State of California convened a group of international experts in microplastics research to identify and characterize the hazards associated with microplastics. Specifically, experts were tasked with identifying which microplastic characteristics (e.g., size, morphology, polymer, etc.) contribute most to toxicity  and developing health-based thresholds for both the aquatic environment  and drinking water . These efforts were limited by critical gaps in knowledge, or a lack of studies the experts deemed fit for the purpose of risk assessment [25, 45, 92]. Here, we identify those shortcomings and the research initiatives needed to address them, which can be grouped into four categories: 1) improved particle selection and characterization for toxicity testing; 2) experimental designs that allow for establishing dose-response curves; 3) the connection of microplastics to established or novel adverse outcome pathways (AOPs); and 4) a clearer understanding of exposure (Fig. 1). Each of the four research gaps are discussed in depth below and recommendations for future study designs are postulated (Table 1).
I. Improved particle characterization and selection for hazard identification and characterization
Assessing potential microplastic toxicity in aquatic organisms has been achieved primarily via laboratory studies in which biota are exposed to microplastics at a given concentration or concentrations and physiological responses are measured. Most exposure studies have been conducted using a single particle type (e.g., polystyrene spheres of a single size), but if particles are well characterized, these studies can provide important information on the potential hazards of specific microplastic types and characteristics (e.g., size, morphology, polymer type, etc.). In addition, there is also a need for studies in which organisms are exposed to combinations of microplastics as close as possible to what they would be exposed to in the ambient environment. For instance, fibers and spheres respectively make up 52–73% and 1–3% of anthropogenic particles detected in the environmental water samples [7, 17, 142], but roughly only 7% of studies published through 2020 use fibers whereas 62% use spheres . Similarly, 82% of studies are conducted with polystyrene or polyethylene polymers, which make up only 5–28% of what is reported in the aquatic environment . Only 12% of aquatic organism tests used weathered particles , which are likely to present greater risks to biota due to increased ingestion probability, leachates, biofilm formation, particle roughness, increased surface area, and potentially other mechanisms [51, 66, 83]. For studies focused on the potential human health impacts of microplastics, similar biases regarding particle selection were observed as 77% of the rodent in vivo studies used polystyrene spheres . In addition, microplastic particles were often limited to a single size (69% of studies), and no studies used weathered particles. This lack of particle diversity is also reflected in in vitro studies.
If particles are comprehensively characterized (see [28, 45] for guidance on minimum particle characterization), experiments that employ a single particle type may provide insight regarding specific relationships between microplastic characteristics and biological effects. Thus, it is recommended that future toxicity tests address one of two experimental objectives. The first is to determine how specific microplastic particle types (e.g., polyester fibers, tire wear particles) and characteristics (e.g., size, surface area, volume) may present a hazard to aquatic organisms and/or humans. Identification of the most harmful microplastic types is important for the development of monitoring programs, as there are numerous measurement techniques that can be used to quantify microplastics, with some being more appropriate and cost-effective for different sizes, morphologies, and polymer types . The second objective is to determine concentrations at which environmentally relevant distributions of microplastics cause adverse effects. The limited particle diversity and incomplete particle characterization in most existing studies are impediments to achieving either objective.
Recommendation 1: Identify microplastic characteristics that best predict hazards through extensive particle characterization and toxicity screening
Results from studies using singular particle types can be extrapolated to more relevant mixtures of microplastics found in the natural environment so long as particles are extensively characterized, and the relative importance of different particle characteristics to toxicological outcomes are understood . For example, Zimmerman et al.  exposed Daphnia magna to polyvinyl chloride, polyurethane, or polylactic acid with or without extractable chemical additives. The particle morphology (i.e., fragments) and size (i.e., 20–40 μm) were held constant. Using this experimental design, Zimmerman et al., could discern which effects were driven by polymer type and which were driven by additive chemicals. Perhaps most importantly, the size, polymer composition, and morphology of the microplastics used were all extensively characterized. These findings provide much-needed insight into which microplastic characteristics may cause toxicity. More similarly designed studies are needed for other types of microplastics to identify which particle characteristics and polymer types are of greatest toxicological concern. Study relevance may be further increased by using particle types frequently most detected in the environment.
Particle size is a critical factor influencing microplastic toxicokinetics and toxicodynamics [25, 49]. In aquatic organisms, smaller microplastics may be taken up via the gills and ingested, while larger plastics may interfere with motility through entanglement [40, 58]. Once a particle is ingested, its size also influences the likelihood for translocation beyond the gut or gills to other tissues [91, 130], as well as their retention and excretion . Current evidence indicates that size strongly affects the observed adverse outcomes, including differential effects on growth , immune function , oxidative stress , and mortality . Many studies suggest that toxic effects are more likely to be observed following exposure to smaller particles , although larger particles may be more harmful to aquatic species in specific scenarios. For example, larger particles take up more volume in the gut once ingested, possibly leading to reduced food assimilation and food dilution [49, 70].
In humans, size determines the extent to which particles may be taken up and distributed within the body. For instance, particles < 10 μm may be inhaled  and those < 1 μm may be taken up by cells [9, 43]. As the size of inhaled particles decreases, translocation efficiency increases . Smaller, orally ingested microplastic particles are also expected to translocate from the gut more efficiently . For instance, 50 and 100 nm polystyrene nanospheres were detected in the liver, spleen, blood, and bone marrow of female rats after 10 days of exposure via gavage. In contrast, particles larger than 100 nm were not detected in the bond marrow and those larger than 300 nm were not detected in the blood . Yet despite these observations, there is insufficient data to reliably model the particokinetics of microplastics for humans  or other organisms , thus increasing uncertainties of risk assessments.
Experiments that disentangle the relative effects of different microplastic morphologies are also needed as particle morphology likely influences retention, translocation, and toxicity. In aquatic organisms, a fiber, defined as having a length to width ratio of three or greater, may be retained in the gut for extended periods of time  or more likely to translocate via its smallest dimension  compared to fragments or spheres with similar particle lengths. Several studies report that fibers or irregularly shaped particles (e.g., fragments) are more toxic than uniform particles such as pellets or spheres [11, 108]. In some instances, specific morphologies may elicit unique adverse effects as fibers have been shown to cause respiratory stress . Similar findings have been described in mammalian studies as fibers have been found to persist in airways in humans , and fragments were found to induce hemolysis in human-derived cells at rates proportionate to their roughness . However, mammalian toxicity studies that use diverse particle morphologies are limited, with most ingestion-based studies using spheres, several using fragments, and none using fibers .
At the interface of size and shape are particle volume and surface area, which were identified as being the primary drivers of food dilution and oxidative stress in aquatic species [49, 70] and used as the basis for thresholds in the ambient environment . Though food dilution is not relevant for human health, similar relationships between surface area and oxidative stress and other adverse effects have been detected in mammalian models. For example, Schmid and Stoeger  found that nanoparticle surface area was highly correlated with acute lung inflammation when in vivo studies in mice and rats were retroactively analyzed. Surface area also influences the formation of the particle corona, which can include toxicants and antigens which influence both uptake and toxicity in humans and other organisms [38, 89]. To date, most studies focused on the influence of surface area on toxicokinetics and toxicodynamics use small, spherical particles (typically less than 1 μm). Additional studies are needed to determine if the previously described relationships between surface area and toxicity persist across larger size ranges and other particle types with high surface area to mass ratios (e.g., fragments, fibers).
In laboratory studies, volume and surface area particle characteristics may be estimated using equations based upon the shape (e.g., volume of a sphere = 4/3 πr^3). To estimate these parameters in environmental particles, modelling techniques may be used . However, particle volume and surface area are not typically measured, estimated, or reported in microplastic occurrence or toxicity studies. Measurement or estimation of such parameters in laboratory studies is crucial to understanding the relevant exposure metric for specific types of toxicological effects. Thus, it is important that studies not only report these characteristics but that they are considered as potential drivers of toxicity in future experiments using aquatic species or rodents.
Finally, experiments designed to decouple particle-driven effects from those caused by chemical leachates (i.e., monomers, additive mixtures) and sorbed chemicals (e.g., ) are critical to understanding the toxicological drivers of microplastics. Adverse effects have been attributed to chemical additives following the inhalation of nylon fibers [104, 126] and polyvinyl chloride particles  in humans; and in aquatic organisms, leachates from tire wear particles [120, 123] and single-use food packing  have been demonstrated to be toxic. Disentangling physical and chemical particle characteristics causing toxicity will facilitate more targeted, efficient management and mitigation strategies for reducing environmental and human health risks from microplastics (e.g., prioritizing assessment of alternatives for chemical additives in plastics).
Though methods for microplastic analysis and particle characterization are still emerging, techniques for quantifying particles as well as determining size, morphology, and polymer type are readily available for most particle types excluding nanoplastics (< 1 μm) [14, 106]. Microplastics are most often enumerated by manually counting particles via visual light microscopy, which may be facilitated by staining particles with nile red. For smaller particles < 20–50 μm, other microscopic or light scattering techniques (e.g., scanning electron microscopy, transmission electron microscopy, dynamic light scattering) are often preferrable. Particle size is most often assessed by manual measurements via microscopy, but other techniques such as dynamic light scattering can be used to generate size distributions. Polymer confirmation and identification are most commonly achieved via Fourier-transform infrared spectroscopy (FTIR) or Raman spectroscopy, but polymers may also be identified using pyrolysis-gas chromatography/mass spectrometry. Other particle characteristics such as surface area and volume may be estimated in some cases [70, 72], but currently, there are no widely used techniques for gathering empirical data describing these characteristics in microplastics. Future methodological studies should seek to develop methods for better particle characterization, particularly for characteristics hypothesized to drive toxicological effects (e.g., surface area, volume).
Recommendation 2: Better characterize microplastic hazards by conducting toxicity tests using polydisperse, environmentally relevant distributions of microplastic particles
To fully characterize the hazards of microplastics, it is important to understand how environmentally relevant mixtures of particles may cause toxicity . Assessing the integrated effects of multiple plastic types from exposures conducted with a single type of microplastic is challenging as some evidence suggests organisms respond differently to diverse mixtures of microplastics (i.e., polydisperse) than each type of microplastic alone. For instance, Ziajahromi et al.,  found polyester fibers or polyethylene beads to be more toxic to Ceriodaphnia dubia when presented alone than when presented as a mixture . There are few studies that have tried to mimic naturally occurring mixtures of microplastics by exposing organisms to more than one particle type at the same time (i.e., ~ 5% of aquatic organism studies, 0% of human health studies ), but more studies are needed to definitively identify the primary hazards of microplastics.
Microplastic distributions vary greatly depending on the environmental matrix [72, 142]. However, some patterns have emerged from studies aimed at describing mixtures of microplastics in the real-world . In drinking water, studies have shown that most samples are typically a mixture of relatively small (< 10 μm) fragments and fibers [102, 103], whereas in the aquatic environment, most surface water and sediment samples, and thus biota, appear to be dominated by fibers and a diverse array of fragments, films, and foams [17, 142]. Toxicity evaluations reflective of these particle distributions would be useful in bridging the gap between laboratory studies and realistic exposures, ultimately leading to better hazard characterization.
Predicting microplastic toxicity may be further complicated by the influence of environmental weathering. Most organisms will encounter microplastics that are weathered , fouled with life (including pathogens ), and that include a sorbed mixture of ambient chemical pollutants (organics and metals ). There is some evidence that particles aged in the natural environment have different bioavailability and toxicity compared to the effects observed from pristine microplastics [16, 21]. Studies have found enhanced effects from microplastics that had been soaked in ocean or lake water compared to virgin microplastics [16, 110]; though in some cases, weathering has been shown to decrease toxicity . Other studies have found increased chances of translocation . Despite this, there is a lack of toxicity data for weathered particles as only roughly 12% of studies used microplastics that were collected from the environment or artificially weathered prior to toxicity tests . The use of weathered particles in future studies will provide more realistic assessments of microplastic toxicity, though it is important that researchers fully describe approaches used for particle weathering to ensure that studies are representative of environmental conditions and repeatable.
Approaches for generating polydisperse, environmentally realistic distributions of microplastics may include the acquisition or generation of the most prevalent particle types typically found within the habitat and matrix of interest. These particles may then be combined in toxicity tests in similar proportions observed in the environment. Artificial weathering can also increase environmental relevance as has been demonstrated in previous studies . Alternatively, some studies have also used field-collected microplastics in toxicity testing [16, 74, 101]. However, if this approach is taken, it is essential that particles are well-characterized as described in Recommendation 1.
II. Inform the development of health-based thresholds for microplastics
Most microplastic toxicity studies are focused on determining if physiological or behavioral effects can be detected, rather than developing robust dose-response data. Though exploratory, hypothesis-driven studies have supplied the field with a foundational understanding of microplastic toxicity effect mechanisms (i.e., hazard identification), studies which generate robust dose-response data are needed to identify critical concentrations at which those effects manifest (i.e., hazard characterization). Thus, future studies should aim to generate robust dose-response data from which critical effect metrics can be derived. Below, we discuss why this is important and provide specific recommendations for future studies seeking to inform health-based thresholds for aquatic organisms and humans.
Recommendation 3: Design experiments to generate robust dose-response data for health-based threshold development
Health-based guidance values are traditionally derived from chronic undefined laboratory studies , though in vitro data may also be used for hazard characterization (see Section III, Recommendation 5). However, it was challenging for the experts in the California Health Effects Workshop to derive health-based thresholds for drinking water and the aquatic environment due to the availability of few fit-for-purpose studies [25, 92]. Of the in vivo studies in the Toxicity of Microplastics Explorer (ToMEx) database, only 52% of human health studies (n = 14) and 44% aquatic organism studies (n = 73) included three or more exposure concentrations in their experimental design . Robust dose-response data is essential to threshold development because it captures the critical points at which contaminant concentrations elicit adverse health effects.
To analyze and describe dose-response relationships, different approaches should be used depending on the specific aims of the study. In environmental toxicology, no observed effect concentrations (NOECs) and lowest observed effect concentrations (LOECs) are often used to inform threshold development for the aquatic environment. Here, it is important to consider that NOECs and LOECs are entirely dependent on the dose selection and experimental design of the study from which they are extracted [36, 75]. For instance, if the LOEC is also the lowest test concentration, it is possible that even lower concentrations not included in the design will induce an adverse biological response. This could result in an underestimation of risk. Conversely, if no effects are observed in a study, the highest observed effect concentration (HONEC) may overestimate risk. Therefore, approaches that consider the whole dose-response curve such as effect concentrations (e.g., ECX) are preferred. Theoretically, only a minimum of three distinct test concentrations are required to derive lethal or effect concentrations of certain percentages (i.e., LCX or ECX, respectively), but a greater number of test concentrations is strongly recommended when possible to ensure that an adequate dose-response relationship may be observed . Of the 162 studies in the ToMEx aquatic organisms database, only 16 report ECX or LCX for distinct species, most of which are cladocerans . This represents a lack of robust dose-response data for aquatic species, particularly for organism groups of regulatory interest such as bivalves and fish.
To understand dose-response relationships for human health, approaches similar to those used for ecological health are often employed. Here, NOEC and LOEC values (referred to as No/Lowest Observed Adverse Effect Levels, NOAELs/LOAELs for human health applications) are often used as a starting point for threshold development [64, 124]. Alternative approaches like Benchmark Dose (BMD) modelling make use of all the data to describe dose-response relationships for a particular endpoint rather than only using discrete experimental concentrations . A significant advantage of the BMD approach is that it provides an estimate of uncertainty via a confidence interval . Another major benefit is that in vitro data may be incorporated into a BMD analysis, so long as quantitative in vitro to in vivo extrapolation models are available (see Section III, Recommendation 5). Yet, despite these advantages, only 53% of evaluated in vivo studies were identified as having acceptable dose-response data appropriate for BMD modelling (i.e., at least three microplastic treatment groups with a concentration range ≥ 3, including control accompanied by estimates of uncertainty such as standard deviation) . Thus, it is recommended that future studies ensure they use a sufficient number and spacing of exposure concentrations as close as possible to the linear range of the dose-response curve, and adequately report uncertainties associated with effects (e.g., standard deviation, 95% confidence intervals).
III. Increase understanding of toxicological pathways induced by microplastics for improved Hazard characterization
Numerous studies have demonstrated the potential for microplastics to cause a wide array of biological effects in aquatic organisms, including oxidative stress , reduced growth [6, 86], tissue damage , reduced reproductive output [26, 57] and behavioral alterations [24, 41, 90]. In rodents, microplastic exposure has been shown to impact endocrine signaling [2, 3, 54], initiate oxidative stress and inflammation [77, 136, 141], and negatively affect reproductive potential [4, 54, 80]. Yet, the specific mechanisms and pathways by which microplastics cause adverse effects are not yet well understood. Many studies provide evidence of altered molecular or cellular-level responses following microplastic exposure [20, 39, 88], but it is often unclear if these observations are indicative of adverse effects at the organism or population level, or if they are merely adaptive and healthy responses (e.g., increased levels of antioxidative enzymes) to a stressor with no significant impact on overall health over longer time periods. In addition, it is unknown if effects observed on apical endpoints such as sperm count in male rodents  are due to general inflammation or more specific mechanisms targeting sensitive tissues such as testis . To address these uncertainties, it is recommended that future studies aim to characterize AOPs by assessing endpoints across multiple levels of biological organization in both humans and aquatic species. Initial efforts to identify AOPs for microplastics have indicated a need for further elucidation of mechanisms linking molecular and whole organism adverse effects . This effort may be accelerated using in vitro systems and a framework for linking in vitro results to in vivo effects . Development of AOPs may also help to understand the interplay of physical and chemical effects from microplastics but should be based on realistic exposure levels .
Recommendation 4: Connect microplastics to existing or novel adverse outcome pathways
Workshop participants agreed that, while not necessary for developing risk-based regulatory thresholds, scientific confidence in thresholds expands when the mode of action of the microplastic related effects and pathways of effect are understood. Such knowledge would facilitate read across attempts which are of importance for microplastics due to their extreme diversity. AOPs provide a powerful conceptual mechanism for creating this linkage, often starting with a molecular initiating event ultimately leading to an effect at the organism level [5, 128]. For aquatic organisms, there is demonstrable evidence ingestion of microplastics can cause food dilution [29, 40, 70, 129] and experts agreed that there is at least partial evidence for the induction of oxidative stress responses following particle translocation . In turn, these pathways were used to form the basis for thresholds for the aquatic environment . However, experts also agreed that these pathways need further development and experimental validation to increase confidence in the derived thresholds . For human health, biomarkers suggestive of effect mechanisms (e.g., oxidative stress, inflammation, reactive oxygen species formation, etc.) have been identified at varying levels of biological organization, however confirmatory linkages to apical endpoints (e.g., sperm reduction in testis) are absent .
Though most toxicity mechanisms for microplastics are only partially understood or have yet to be explored, some recent studies have proposed partial AOPs or hypothesized which existing AOPs may be applicable to microplastics [55, 61, 62, 67, 85]. For instance, following a systematic literature review, Jeong and Choi identified several putative AOPs to which nano- and microplastics could be connected, leading to adverse outcomes on growth, reproduction, and survival following oxidative stress . Similarly, Coffin et al.  noted that several rodent studies found that microplastic ingestion induced oxidative stress responses in conjunction with impacts to reproductive biomarkers (e.g., [4, 136]), and that some responses had similarities with key events described in AOPs characterizing generalized inflammatory responses . While it may be reasonable to assume that these observations are directly related, these effects have yet to be linked by distinct key event relationships and experimentally observed within the same network of events. Furthermore, uncertainties with regards to particle characterization (e.g., verification of the absence of chemical additives or impurities) in these studies prevent direct linking of molecular endpoints to apical endpoints . Future studies should aim to identify and develop AOPs for microplastics using one or more strategies (summarized by ). An example of this might be top-down development where researchers may begin with a well-defined adverse outcome at the organismal level and work their way down biological levels of organization. Researchers should also draw upon existing AOP knowledge, for example by using the AOP-wiki (aopwiki.org) or AOP knowledgebase (aopkb.oecd.org), as these pathways are not contaminant-specific and multiple contaminants may share the same AOP. Thus, it is likely that some existing AOPs may inform microplastic effect mechanisms and require only experimental validation. Even if the primary goal of the study is outside the scope of AOP development, researchers should always strive to describe cascades of specific biological responses and include endpoints across biological levels of organization. This is particularly important for aquatic organisms, and making mechanistic linkages between the cellular, organismal, population, and community levels can be achieved with carefully designed mesocosm or macrocosm approaches.
Recommendation 5: Increase the relevance of in vitro studies for hazard characterization by developing a framework for extrapolating in vitro results to in vivo effects
In vitro approaches in toxicology have become more widespread as new applications are developed and reductions in animal testing are encouraged [94, 98]. However, the use of such data for developing management thresholds is currently limited due to unclear methods for reliably extrapolating in vitro results to potential in vivo effects for particles , though strategies for soluble chemicals have been previously developed . If reliable methods for extrapolating in vitro results to in vivo effects are established, researchers may take advantage of the cost, resource, and time benefits often provided by in vitro systems while generating meaningful data that can be used to characterize the hazards of microplastics. In vitro approaches could also be used as part of a tiered system, with the use of cell lines as a screening tool to prioritize which particle sizes, morphologies, etc. should be studied in costlier in vivo models. This strategy has been used and is recommended for soluble chemicals such as endocrine disruptors (e.g., ). In the United States, development of a quantitative in vitro to in vivo extrapolation model for microplastics and other contaminants may be necessary to conduct risk assessments due to the mandate phasing out the use of in vivo studies by the United States Environmental Protection Agency by 2035 .
Microplastics are different from many other contaminants because they are comprised of both chemical and physical constituents and behave as colloid particles that can settle, diffuse, and agglomerate differentially. This presents a challenge in seeking to develop a tool for the extrapolation of in vitro data. For instance, buoyant microplastics may rapidly move away from the cell surface in an unagitated system, resulting in an exceedingly low effective concentration . Thus, in addition to the concentration and exposure duration, particle (e.g., size, density, buoyancy, surface chemistry) and media characteristics (e.g., viscosity, density, presence of proteins) must be extensively described to fully understand differences between in vitro and in vivo test systems. A second, unique challenge is that the organ partitioning of microplastics in vivo is not dictated by hydrophobicity as is the case for many chemical contaminants, but rather the phagocytic capacity of the organ [32, 105]. There are some interesting developments that may help in addressing the challenges associated with microplastic exposures in vitro, including the use of semi-wet [76, 95], inverted culture systems [18, 119, 131], or dynamically flowing systems such as cell-on-a-chip models, which may facilitate cell-particle contact.
Novel computation approaches need to be further developed to support the incorporation of in vitro data from microplastic studies into risk assessment exercises. This firstly includes the use of dosimetry models, specifically tailored to capture the particle dynamics in vitro such as the In vitro Sedimentation, Diffusion and Dosimetry, In vitro Sedimentation, Diffusion, Dissolution, and Dosimetry, and Distorted Grid models [30, 31, 52, 122] which provide time-dependent particle and aggregate concentrations at any given height in the media column. Secondly, efforts have also been made to predict in vivo microplastic concentrations based on results from in vitro studies using Physiologically Based Kinetic (PBK) models which take into account the partitioning of particle-based on phagocytic capacity as described earlier . Thus far, PBK models have been developed for quantum dots (20 nm) , metallic nanoparticles (Bachler et al., 2013), titanium dioxide (15-150 nm) , nanocrystals and some polymers such as PLGA (50-135 nm) [22, 79]. In a final step, PBK models can be used in quantitative in vitro to in vivo extrapolations of observed effects [65, 107]. Though these efforts demonstrate the possibility of in vitro to in vivo extrapolation for microplastics, research investments for improving estimates of dosimetry and generating reliable data describing the transport and partitioning of microplastic particles in vivo are warranted.
IV Improved exposure assessment for microplastics
Recommendation 6: Characterize understudied microplastic exposure routes
The primary purpose of this working group was hazard identification and characterization for the purposes of health-based threshold development. However, there is also a need for better microplastic exposure assessment to improve future assessments of risk. Most microplastic toxicity studies have focused on a limited number of exposure routes. For aquatic organisms, most studies have added microplastics to water [15, 56]. However, effective risk assessment and management require a holistic understanding of relative contributions from multiple sources with a similar route of exposure (e.g., ingestion, dermal, inhalation). While this working group largely focused on aqueous exposures, aquatic organisms, particularly those species associated with the benthos, are likely to be exposed to microplastics via the sediment, which generally have higher microplastic concentrations than the water column . Thus, it is recommended that future studies aim to evaluate microplastic exposure and toxicity in aquatic organisms in sediment and conduct depth-integrated risk assessments.
Here, ingestion-based studies where microplastics were added to food  or drinking water (Hou et al., 2020, ) or administered via oral gavage (e.g., ) were the primary focus. However, humans are exposed to microplastics via a wide variety of sources including food, and air . The relative contribution of these sources to microplastic exposure, uptake, and toxicity are not well characterized in humans. Relative source contribution from drinking water was identified as the most sensitive parameter in the derivation of a health-based guidance level for drinking water . As such, it is recommended that future studies aim to evaluate microplastic exposures such that a comprehensive exposure assessment through all relevant sources may be conducted. Having a comprehensive understanding of exposure for both will allow for more reliable estimations of risks that microplastics may pose to humans.
The field of microplastics research has reached the point where there is no longer any doubt of widespread exposure of animals and humans to plastic particles. This has led the management community to seek advice regarding whether there is a need to set limits, and what those limits should be, for microplastics in drinking water, foods, and the natural environment. Research into the bioavailability and effects of microplastics have demonstrated that microplastics can cause harm, but it is often the case that these studies cannot readily inform risk assessments. Here, we have discussed the research gaps that need to be filled to increase our understanding of the risk microplastics pose to biota and humans and best advise managers on setting health-based thresholds in a more accurate and relevant way. Such data are essential for researchers to understand the extent to which microplastics, varying in size, shape, and chemical profile, at environmentally relevant concentrations, and capturing myriad exposure pathways, pose a risk to human health and the health of aquatic species, biodiversity, and ecosystems. With increased understanding, we can adapt management strategies and risk assessments to help effectively and efficiently manage this novel contaminant.
Availability of data and materials
The Toxicity of Microplastics Explorer (ToMEx) databases, web applications, and source code may be accessed at https://microplastics.sccwrp.org.
Adverse Outcome Pathway
Highest observed effect concentration
Lowest observed adverse effect level
Lowest observed effect concentration
No observed adverse effect level
No observed effect concentration
Physiologically Based Kinetic
Toxicity of Microplastics Explorer
Amaral-Zettler LA, Zettler ER, Mincer TJ. Ecology of the plastisphere. Nat Rev Microbiol. 2020;18(3):139–51.
Amereh F, Babaei M, Eslami A, Fazelipour S, Rafiee M. The emerging risk of exposure to nano (micro) plastics on endocrine disturbance and reproductive toxicity: from a hypothetical scenario to a global public health challenge. Environ Pollut. 2020;261:114158.
Amereh F, Eslami A, Fazelipour S, Rafiee M, Zibaii MI, Babaei M. Thyroid endocrine status and biochemical stress responses in adult male Wistar rats chronically exposed to pristine polystyrene nanoplastics. Toxicol Res. 2019;8(6):953–63.
An R, Wang X, Yang L, Zhang J, Wang N, Xu F, et al. Polystyrene microplastics cause granulosa cells apoptosis and fibrosis in ovary through oxidative stress in rats. Toxicology. 2021;449:152665.
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, et al. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 2010;29(3):730–41.
Athey SN, Albotra SD, Gordon CA, Monteleone B, Seaton P, Andrady AL, et al. Trophic transfer of microplastics in an estuarine food chain and the effects of a sorbed legacy pollutant. Limnol Oceanograph Lett. 2020;5(1):154–62.
Athey SN, Erdle LM. Are we underestimating anthropogenic microfiber pollution? A Critical Review of Occurrence, Methods, and Reporting. Environ Toxicol Chem. 2021;41(4):822–37.
Bachler G, von Goetz N, Hungerbuhler K. Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles. Nanotoxicology. 2015;9(3):373–80.
Beier R, Gebert A. Kinetics of particle uptake in the domes of Peyer’s patches. American journal of physiology-gastrointestinal and liver. Physiology. 1998;275(1):G130–7.
Belanger S, Barron M, Craig P, Dyer S, Galay-Burgos M, Hamer M, et al. Future needs and recommendations in the development of species sensitivity distributions: estimating toxicity thresholds for aquatic ecological communities and assessing impacts of chemical exposures. Integr Environ Assess Manag. 2017;13(4):664–74.
Botterell ZLR, Beaumont N, Cole M, Hopkins FE, Steinke M, Thompson RC, et al. Bioavailability of microplastics to marine zooplankton: effect of shape and Infochemicals. Environ Sci Technol. 2020;54(19):12024–33.
Bouwmeester H, Hollman PCH, Peters RJB. Potential health impact of environmentally released Micro- and Nanoplastics in the human food production chain: experiences from Nanotoxicology. Environ Sci Technol. 2015;49(15):8932–47.
Brahney J, Hallerud M, Heim E, Hahnenberger M, Sukumaran S. Plastic rain in protected areas of the United States. Science. 2020;368(6496):1257–60.
Brander SM, Renick VC, Foley MM, Steele C, Woo M, Lusher A, et al. Sampling and quality assurance and quality control: a guide for scientists investigating the occurrence of microplastics across matrices. Appl Spectrosc. 2020;74(9):1099–125.
Bucci K, Tulio M, Rochman C. What is known and unknown about the effects of plastic pollution: A meta-analysis and systematic review. Ecol Appl. 2020;30:e02044.
Bucci K, Bikker J, Stevack K, Watson-Leung T, Rochman C. Impacts to larval fathead minnows vary between Preconsumer and environmental microplastics. Environ Toxicol Chem. 2021;41:858–68.
Burns EE, Boxall ABA. Microplastics in the aquatic environment: evidence for or against adverse impacts and major knowledge gaps. Environ Toxicol Chem. 2018;37(11):2776–96.
Busch M, Kämpfer AAM, Schins RPF. An inverted in vitro triple culture model of the healthy and inflamed intestine: adverse effects of polyethylene particles. Chemosphere. 2021;284:131345.
California State Water Resources Control Board (CSWRCB). Adoption of definition of ‘microplastics in drinking water’. Resolution No 2020–0021. (2020). https://www.waterboards.ca.gov/board_decisions/adopted_orders/resolutions/2020/rs2020_0021.pdf.
Canesi L, Ciacci C, Bergami E, Monopoli MP, Dawson KA, Papa S, et al. Evidence for immunomodulation and apoptotic processes induced by cationic polystyrene nanoparticles in the hemocytes of the marine bivalve Mytilus. Mar Environ Res. 2015;111:34–40.
Capó X, Company JJ, Alomar C, Compa M, Sureda A, Grau A, et al. Long-term exposure to virgin and seawater exposed microplastic enriched-diet causes liver oxidative stress and inflammation in gilthead seabream Sparus aurata, Linnaeus 1758. Sci Total Environ. 2021;767:144976.
Carlander U, Li D, Jolliet O, Emond C, Johanson G. Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles. Int J Nanomedicine. 2016;11:625–40.
Choi D, Bang J, Kim T, Oh Y, Hwang Y, Hong J. In vitro chemical and physical toxicities of polystyrene microfragments in human-derived cells. J Hazard Mater. 2020;400:123308.
Choi JS, Jung YJ, Hong NH, Hong SH, Park JW. Toxicological effects of irregularly shaped and spherical microplastics in a marine teleost, the sheepshead minnow (Cyprinodon variegatus). Mar Pollut Bull. 2018;129(1):231–40.
Coffin S, Bouwmeester H, Brander S, Damdimopoulou P, Gouin T, Hermabessiere L, et al. Development and application of a health-based framework for informing regulatory action in relation to exposure of microplastic particles in California drinking water. Microplast Nanoplast. 2022;2(1):12.
Cole M, Lindeque P, Fileman E, Halsband C, Galloway TS. The impact of polystyrene microplastics on feeding, function and fecundity in the marine copepod Calanus helgolandicus. Environ Sci Technol. 2015;49(2):1130–7.
De Frond H, Thornton Hampton L, Kotar S, Gesulga K, Matuch C, Lao W, et al. Monitoring microplastics in drinking water: An interlaboratory study to inform effective methods for quantifying and characterizing microplastics. Chemosphere. 2022;298:134282.
de Ruijter VN, Redondo-Hasselerharm PE, Gouin T, Koelmans AA. Quality criteria for microplastic effect studies in the context of risk assessment: a critical review. Environ Sci Technol. 2020;54(19):11692–705.
De Sales-Ribeiro C, Brito-Casillas Y, Fernandez A, Caballero MJ. An end to the controversy over the microscopic detection and effects of pristine microplastics in fish organs. Sci Rep. 2020;10(1):12434.
DeLoid G, Cohen JM, Darrah T, Derk R, Rojanasakul L, Pyrgiotakis G, et al. Estimating the effective density of engineered nanomaterials for in vitro dosimetry. Nat Commun. 2014;5(1):3514.
DeLoid GM, Cohen JM, Pyrgiotakis G, Pirela SV, Pal A, Liu J, et al. Advanced computational modeling for in vitro nanomaterial dosimetry. Part Fibre Toxicol. 2015;12(1):32.
Deng L, Liu H, Ma Y, Miao Y, Fu X, Deng Q. Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles. Toxicol Appl Pharmacol. 2019;384:114765.
EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain). Statement on the presence of microplastics and nanoplastics in food, with particular focus on seafood. EFSA J. 2016;14(6):4501.
EFSA Scientific Committee, Hardy A, Benford D, Halldorsson T, Jeger MJ, Knutsen KH, et al. Update: use of the benchmark dose approach in risk assessment. EFSA J. 2017;15(1):e04658.
Erni-Cassola G, Zadjelovic V, Gibson MI, Christie-Oleza JA. Distribution of plastic polymer types in the marine environment; A meta-analysis. J Hazard Mater. 2019;369:691–8.
European Chemicals Agency (ECHA). Guidance on information requirements and chemical safety assessment, Chapter R.10: Characterisation of dose [concentration]-response for environment. 2012.
European chemicals agency (ECHA). Annex XV restriction report, proposal for a restriction of intentionally added microplastics. Version 1.2. 2019.
Evans SM, Ashwood P, Warley A, Berisha F, Thompson RPH, Powell JJ. The role of dietary microparticles and calcium in apoptosis and interleukin-1beta release of intestinal macrophages. Gastroenterology. 2002;123(5):1543–53.
Franzellitti S, Capolupo M, Wathsala R, Valbonesi P, Fabbri E. The multixenobiotic resistance system as a possible protective response triggered by microplastic ingestion in Mediterranean mussels (Mytilus galloprovincialis): larvae and adult stages. Compar Biochem Physiol Part C. 2019;219:50–8.
Galloway TS, Cole M, Lewis C. Interactions of microplastic debris throughout the marine ecosystem. Nature Ecol Evol. 2017;1(5):0116.
Gambardella C, Morgana S, Ferrando S, Bramini M, Piazza V, Costa E, et al. Effects of polystyrene microbeads in marine planktonic crustaceans. Ecotoxicol Environ Saf. 2017;145:250–7.
Gardon T, Huvet A, Paul-Pont I, Cassone AL, Sham Koua M, Soyez C, et al. Toxic effects of leachates from plastic pearl-farming gear on embryo-larval development in the pearl oyster Pinctada margaritifera. Water Res. 2020;179:115890.
Geiser M, Schürch S, Gehr P. Influence of surface chemistry and topography of particles on their immersion into the lung’s surface-lining layer. J Appl Physiol. 2003;94(5):1793–801.
German Federal Institute for Risk Assessment (BfR), Department of Food Safety, Unit Effect-based Analytics and Toxicogenomics Unit and Nanotoxicology Junior Research Group, Berlin, Germany, Shopova S, Sieg H, Braeuning A. Risk assessment and toxicological research on micro- and nanoplastics after oral exposure via food products. EFSA J. 2020;18(S1):e181102.
Gouin T, Ellis-Hutchings R, Thornton Hampton LM, Lemieux CL, Wright SL. Screening and prioritization of nano- and microplastic particle toxicity studies for evaluating human health risks – development and application of a toxicity study assessment tool. Microplast Nanoplast. 2022;2(1):2.
Gray AD, Weinstein JE. Size- and shape-dependent effects of microplastic particles on adult daggerblade grass shrimp (Palaemonetes pugio). Environ Toxicol Chem. 2017;36(11):3074–80.
Gray LE, Ostby J, Wilson V, Lambright C, Bobseine K, Hartig P, et al. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps. Toxicology. 2002;181–182:371–82.
Halden RU, Rolsky C, Khan FR. Time: a key driver of uncertainty when assessing the risk of environmental plastics to human health. Environ Sci Technol. 2021;55(19):12766–9.
Hampton LMT, Brander SM, Coffin S, Cole M, Hermabessiere L, Koelmans AA, Rochman CM. Characterizing microplastic hazards: Which concentration metrics and particle characteristics are most informative for understanding toxicity in aquatic organisms? Microplastics and Nanoplastics. In Review.
Hampton LMT, Lowman H, Coffin S, Darin E, De Frond H, Hermabessiere L, et al. A living tool for the continued exploration of microplastic toxicity. Microplast Nanoplast. 2022;2(1):13.
Hariharan G, Purvaja R, Anandavelu I, Robin RS, Ramesh R. Accumulation and ecotoxicological risk of weathered polyethylene (wPE) microplastics on green mussel (Perna viridis). Ecotoxicol Environ Saf. 2021;208:111765.
Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, et al. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol. 2010;7(1):36.
Horton AA, Walton A, Spurgeon DJ, Lahive E, Svendsen C. Microplastics in freshwater and terrestrial environments: evaluating the current understanding to identify the knowledge gaps and future research priorities. Sci Total Environ. 2017;586:127–41.
Hou J, Lei Z, Cui L, Hou Y, Yang L, An R, et al. Polystyrene microplastics lead to pyroptosis and apoptosis of ovarian granulosa cells via NLRP3/Caspase-1 signaling pathway in rats. Ecotoxicol Environ Saf. 2021;212:112012.
Hu M, Palić D. Micro- and nano-plastics activation of oxidative and inflammatory adverse outcome pathways. Redox Biol. 2020;37:101620.
Jacob H, Besson M, Swarzenski PW, Lecchini D, Metian M. Effects of virgin Micro- and Nanoplastics on fish: trends, Meta-analysis, and perspectives. Environ Sci Technol. 2020;54(8):4733–45.
Jaikumar G, Brun NR, Vijver MG, Bosker T. Reproductive toxicity of primary and secondary microplastics to three cladocerans during chronic exposure. Environ Pollut. 2019;249:638–46.
Jâms IB, Windsor FM, Poudevigne-Durance T, Ormerod SJ, Durance I. Estimating the size distribution of plastics ingested by animals. Nat Commun. 2020;11(1):1594.
Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol. 1990;42(12):821–6.
Jeong CB, Won EJ, Kang HM, Lee MC, Hwang DS, Hwang UK, et al. Microplastic size-dependent toxicity, oxidative stress induction, and p-JNK and p-p38 activation in the Monogonont rotifer (Brachionus koreanus). Environ Sci Technol. 2016;50(16):8849–57.
Jeong J, Choi J. Adverse outcome pathways potentially related to hazard identification of microplastics based on toxicity mechanisms. Chemosphere. 2019;231:249–55.
Jeong J, Choi J. Development of AOP relevant to microplastics based on toxicity mechanisms of chemical additives using ToxCast and deep learning models combined approach. Environ Int. 2020;137:105557.
Jin Y, Xia J, Pan Z, Yang J, Wang W, Fu Z. Polystyrene microplastics induce microbiota dysbiosis and inflammation in the gut of adult zebrafish. Environ Pollut. 2018;235:322–9.
Joint FAO/WHO Expert Committee on Food Additives. Meeting (63rd : 2005 : Geneva S, International Programme on Chemical Safety. Safety evaluation of certain food additives / prepared by the sixty-third meeting of the Joint FAO/WHO Expert Committee on Food Additives (JEFCA). 2006; Available from: https://apps.who.int/iris/handle/10665/43265.
Kasteel EEJ, Lautz LS, Culot M, Kramer NI, Zwartsen A. Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: a case-study for baclofen. Toxicol in Vitro. 2021;76:105223.
Khosrovyan A, Kahru A. Evaluation of the potential toxicity of UV-weathered virgin polyamide microplastics to non-biting midge Chironomus riparius. Environ Pollut. 2021;287:117334.
Kim Y, Jeong J, Lee S, Choi I, Choi J. Identification of adverse outcome pathway related to high-density polyethylene microplastics exposure: Caenorhabditis elegans transcription factor RNAi screening and zebrafish study. J Hazard Mater. 2020;388:121725.
Kinjo A, Mizukawa K, Takada H, Inoue K. Size-dependent elimination of ingested microplastics in the Mediterranean mussel Mytilus galloprovincialis. Mar Pollut Bull. 2019;149:110512.
Koelmans AA, Mohamed Nor NH, Hermsen E, Kooi M, Mintenig SM, De France J. Microplastics in freshwaters and drinking water: critical review and assessment of data quality. Water Res. 2019;155:410–22.
Koelmans AA, Redondo-Hasselerharm PE, Mohamed Nor NH, Kooi M. Solving the nonalignment of methods and approaches used in microplastic research to consistently characterize risk. Environ Sci Technol. 2020;54:12307–15.
Kooi M, Koelmans AA. Simplifying microplastic via continuous probability distributions for size, shape, and density. Environ Sci Technol Lett. 2019;6(9):551–7.
Kooi M, Primpke S, Mintenig SM, Lorenz C, Gerdts G, Koelmans AA. Characterizing the multidimensionality of microplastics across environmental compartments. Water Res. 2021;202:117429.
Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol. 2009;21:55–60.
Kühn S, van Oyen A, Booth AM, Meijboom A, van Franeker JA. Marine microplastic: preparation of relevant test materials for laboratory assessment of ecosystem impacts. Chemosphere. 2018;213:103–13.
Landis WG, Chapman PM. Well past time to stop using NOELs and LOELs. Integr Environ Assess Manag. 2011;7(4):vi–viii.
Lehner R, Wohlleben W, Septiadi D, Landsiedel R, Petri-Fink A, Rothen-Rutishauser B. A novel 3D intestine barrier model to study the immune response upon exposure to microplastics. Arch Toxicol. 2020;94(7):2463–79.
Li B, Ding Y, Cheng X, Sheng D, Xu Z, Rong Q, et al. Polyethylene microplastics affect the distribution of gut microbiota and inflammation development in mice. Chemosphere. 2020;244:125492.
Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano. 2010;4(11):6303–17.
Li M, Panagi Z, Avgoustakis K, Reineke J. Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content. Int J Nanomedicine. 2012;7:1345–56.
Li S, Wang Q, Yu H, Yang L, Sun Y, Xu N, et al. Polystyrene microplastics induce blood–testis barrier disruption regulated by the MAPK-Nrf2 signaling pathway in rats. Environ Sci Pollut Res. 2021a;28(35):47921–31.
Li Z, Feng C, Pang W, Tian C, Zhao Y. Nanoplastic-induced genotoxicity and intestinal damage in freshwater benthic clams (Corbicula fluminea): comparison with microplastics. ACS Nano. 2021b;15(6):9469–81.
Lin P, Chen J-W, Chang LW, Wu J-P, Redding L, Chang H, et al. Computational and ultrastructural toxicology of a nanoparticle, quantum dot 705. Mice Environ Sci Technol. 2008;42(16):6264–70.
Liu P, Zhan X, Wu X, Li J, Wang H, Gao S. Effect of weathering on environmental behavior of microplastics: properties, sorption and potential risks. Chemosphere. 2020;242:125193.
Liu P, Shi Y, Wu X, Wang H, Huang H, Guo X, et al. Review of the artificially-accelerated aging technology and ecological risk of microplastics. Sci Total Environ. 2021a;768:144969.
Liu Z, Li Y, Sepúlveda MS, Jiang Q, Jiao Y, Chen Q, et al. Development of an adverse outcome pathway for nanoplastic toxicity in Daphnia pulex using proteomics. Sci Total Environ. 2021b;766:144249.
Lo HKA, Chan KYK. Negative effects of microplastic exposure on growth and development of Crepidula onyx. Environ Pollut. 2018;233:588–95.
Lu C, Kania PW, Buchmann K. Particle effects on fish gills: An immunogenetic approach for rainbow trout and zebrafish. Aquaculture. 2018;484:98–104.
Lu Y, Zhang Y, Deng Y, Jiang W, Zhao Y, Geng J, et al. Uptake and accumulation of polystyrene microplastics in zebrafish (Danio rerio) and toxic effects in liver. Environ Sci Technol. 2016;50(7):4054–60.
Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. PNAS. 2008;105(38):14265–70.
Lwanga HE, Gertsen H, Gooren H, Peters P, Salanki T, van der Ploeg M, et al. Incorporation of microplastics from litter into burrows of Lumbricus terrestris. Environ Pollut. 2017;220(Pt A):523–31.
McIlwraith HK, Kim J, Helm P, Bhavsar SP, Metzger JS, Rochman CM. Evidence of microplastic translocation in wild-caught fish and implications for microplastic accumulation dynamics in food webs. Environ Sci Technol. 2021;55(18):12372–82.
Mehinto AC, Coffin S, Koelmans A, Brander SM, Wagner M, Hampton L, et al. Risk-based management framework for microplastics in aquatic ecosystems. Microplast Nanoplast. Accepted.
Mohamed Nor NH, Kooi M, Diepens NJ, Koelmans AA. Lifetime accumulation of microplastic in children and adults. Environ Sci Technol. 2021;55(8):5084–96.
National Research Council. Toxicity testing in the 21st century: a vision and a strategy [internet]. Washington, DC: The National Academies Press; 2007. Available from: https://www.nap.edu/catalog/11970/toxicity-testing-in-the-21st-century-a-vision-and-a
Navabi N, McGuckin MA, Lindén SK. Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation. PLoS One. 2013;8(7):e68761.
Omenn GS, Merchant J, Boatman E, Dement JM, Kuschner M, Nicholson W, et al. Contribution of environmental fibers to respiratory cancer. Environ Health Perspect. 1986;70:51–6.
Organisation for Economic Co-operation and Development (OECD). Current Approaches in the Statistical Analysis of Ecotoxicity Data: A guidance to application (annexes to this publication exist as a separate document). Paris: OECD Series on Testing and Assessment; 2006. Report No.: 54
Organisation for Economic Co-operation and Development (OECD). Guidance Document on Good In Vitro Method Practices (GIVIMP). Paris: OECD Series on Testing and Assessment; 2018. Report No.: 286
Park EJ, Han JS, Park EJ, Seong E, Lee GH, Kim DW, et al. Repeated-oral dose toxicity of polyethylene microplastics and the possible implications on reproduction and development of the next generation. Toxicol Lett. 2020;324:75–85.
Parliament. House of Commons (2016). Environmental impact of microplastics. (HC 1979). London: house of commons, Environmental Audit Committee.
Peters R, de Jong N, de Haan L, Wright S, Bouwmeester H. Release and intestinal translocation of chemicals associated with microplastics in an in vitro human gastrointestinal digestion model. Microplast Nanoplast. 2022;2(1):3.
Pivokonsky M, Cermakova L, Novotna K, Peer P, Cajthaml T, Janda V. Occurrence of microplastics in raw and treated drinking water. Sci Total Environ. 2018;643:1644–51.
Pivokonský M, Pivokonská L, Novotná K, Čermáková L, Klimtová M. Occurrence and fate of microplastics at two different drinking water treatment plants within a river catchment. Sci Total Environ. 2020;741:140236.
Porter DW, Castranova V, Robinson V, Hubbs AF, Mercer RR, Scabilloni J, et al. Acute inflammatory reaction in rats after intratracheal instillation of material collected from a nylon flocking plant. J Toxic Environ Health A. 1999;57(1):25–45.
Praetorius A, Tufenkji N, Goss K-U, Scheringer M, von der Kammer F, Elimelech M. The road to nowhere: equilibrium partition coefficients for nanoparticles. Environ Sci. 2014;1(4):317–23.
Primpke S, Christiansen SH, Cowger W, Frond HD, Deshpande A, Fischer M, et al. Critical assessment of analytical methods for the harmonized and cost-efficient analysis of microplastics. Appl Spectrosc. 2020;74(9):1012–47.
Punt A, Aartse A, Bovee TFH, Gerssen A, van Leeuwen SPJ, Hoogenboom RLAP, et al. Quantitative in vitro-to-in vivo extrapolation (QIVIVE) of estrogenic and anti-androgenic potencies of BPA and BADGE analogues. Arch Toxicol. 2019;93(7):1941–53.
Qiao R, Deng Y, Zhang S, Wolosker MB, Zhu Q, Ren H, et al. Accumulation of different shapes of microplastics initiates intestinal injury and gut microbiota dysbiosis in the gut of zebrafish. Chemosphere. 2019;236:124334.
Ramsperger AFRM, Narayana VKB, Gross W, Mohanraj J, Thelakkat M, Greiner A, et al. Environmental exposure enhances the internalization of microplastic particles into cells. Sci Adv. 2020;6(50):eabd1211.
Rochman CM, Hoh E, Kurobe T, Teh SJ. Ingested plastic transfers hazardous chemicals to fish and induces hepatic stress. Sci Rep. 2013;3:3263.
Rochman CM, Brookson C, Bikker J, Djuric N, Earn A, Bucci K, et al. Rethinking microplastics as a diverse contaminant suite. Environ Toxicol Chem. 2019;38(4):703–11.
Rochman CM. The complex mixture, fate and toxicity of chemicals associated with plastic debris in the marine environment. Marine Anthropog Litter. 2015:117–40.
Romeo D, Salieri B, Hischier R, Nowack B, Wick P. An integrated pathway based on in vitro data for the human hazard assessment of nanomaterials. Environ Int. 2020;137:105505.
Schmid O, Stoeger T. Surface area is the biologically most effective dose metric for acute nanoparticle toxicity in the lung. J Aerosol Sci. 2016;99:133–43.
Schultz CL, Bart S, Lahive E, Spurgeon DJ. What is on the outside matters—surface charge and dissolve organic matter association affect the toxicity and physiological mode of action of polystyrene Nanoplastics to C. elegans. Environ Sci Technol. 2021;55(9):6065–75.
Silva CJM, Silva ALP, Gravato C, Pestana JLT. Ingestion of small-sized and irregularly shaped polyethylene microplastics affect Chironomus riparius life-history traits. Sci Total Environ. 2019;672:862–8.
Stadnicka-Michalak J, Tanneberger K, Schirmer K, Ashauer R. Measured and modeled Toxicokinetics in cultured fish cells and application to in vitro - in vivo toxicity extrapolation. PLoS One. 2014;9(3):e92303.
Stienbarger CD, Joseph J, Athey SN, Monteleone B, Andrady AL, Watanabe WO, et al. Direct ingestion, trophic transfer, and physiological effects of microplastics in the early life stages of Centropristis striata, a commercially and recreationally valuable fishery species. Environ Pollut. 2021;285:117653.
Stock V, Böhmert L, Dönmez MH, Lampen A, Sieg H. An inverse cell culture model for floating plastic particles. Anal Biochem. 2020;591:113545.
Tamis JE, Koelmans AA, Dröge R, Kaag NHBM, Keur MC, Tromp PC, et al. Environmental risks of car tire microplastic particles and other road runoff pollutants. Microplast Nanoplast. 2021;1(1):10.
ter Halle A, Ladirat L, Martignac M, Mingotaud AF, Boyron O, Perez E. To what extent are microplastics from the open ocean weathered? Environ Pollut. 2017;227:167–74.
Thomas DG, Smith JN, Thrall BD, Baer DR, Jolley H, Munusamy P, et al. ISD3: a particokinetic model for predicting the combined effects of particle sedimentation, diffusion and dissolution on cellular dosimetry for in vitro systems. Part Fibre Toxicol. 2018;15(1):6.
Tian Z, Zhao H, Peter KT, Gonzalez M, Wetzel J, Wu C, et al. A ubiquitous tire rubber–derived chemical induces acute mortality in coho salmon. Science. 2021;371(6525):185–9.
United States Environmental Protection Agency (USEPA). Benchmark Dose Technical Guidance. 2012. Report No.: EPA/100/R-12/001.
United States Environmental Protection Agency (USEPA). Administrator Wheeler Signs Memo to Reduce Animal Testing, Awards $4.25 Million to Advance Research on Alternative Methods to Animal Testing [Internet]. 2019 [cited 2021 Nov 21]. Available from: https://www.epa.gov/newsreleases/administrator-wheeler-signs-memo-reduce-animal-testing-awards-425-million-advance.
van Dijk F, Song S, van Eck GWA, Wu X, Bos IST, Boom DHA, et al. Inhalable textile microplastic fibers impair lung repair. bioRxiv. 2021.
Villeneuve DL, Landesmann B, Allavena P, Ashley N, Bal-Price A, Corsini E, et al. Representing the process of inflammation as key events in adverse outcome pathways. Toxicol Sci. 2018;163(2):346–52.
Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, et al. Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci. 2014;142(2):312–20.
Walkinshaw C, Lindeque PK, Thompson R, Tolhurst T, Cole M. Microplastics and seafood: lower trophic organisms at highest risk of contamination. Ecotoxicol Environ Saf. 2020;190:110066.
Wang S, Hu M, Zheng J, Huang W, Shang Y, Kar-Hei Fang J, et al. Ingestion of nano/micro plastic particles by the mussel Mytilus coruscus is size dependent. Chemosphere. 2021;263:127957.
Watson CY, DeLoid GM, Pal A, Demokritou P. Buoyant nanoparticles: implications for Nano-biointeractions in cellular studies. Small. 2016;12(23):3172–80.
World Health Organization (WHO). Microplastics in drinking water. Geneva. 2019.
Wilcox C, Hardesty BD, Law KL. Abundance of floating plastic particles is increasing in the Western North Atlantic Ocean. Environ Sci Technol. 2020;54(2):790–6.
Wright SL, Kelly FJ. Plastic and human health: a Micro issue? Environ Sci Technol. 2017;51(12):6634–47.
Wright SL, Ulke J, Font A, Chan KLA, Kelly FJ. Atmospheric microplastic deposition in an urban environment and an evaluation of transport. Environ Int. 2020;136:105411.
Xie X, Deng T, Duan J, Xie J, Yuan J, Chen M. Exposure to polystyrene microplastics causes reproductive toxicity through oxidative stress and activation of the p38 MAPK signaling pathway. Ecotoxicol Environ Saf. 2020;190:110133.
Xiong X, Tu Y, Chen X, Jiang X, Shi H, Wu C, et al. Ingestion and egestion of polyethylene microplastics by goldfish (Carassius auratus): influence of color and morphological features. Heliyon. 2019;5(12):e03063.
Xu C, Zhang B, Gu C, Shen C, Yin S, Aamir M, et al. Are we underestimating the sources of microplastic pollution in terrestrial environment? J Hazard Mater. 2020;400:123228.
Xu H, Dinsdale D, Nemery B, Hoet PHM. Role of residual additives in the cytotoxicity and cytokine release caused by polyvinyl chloride particles in pulmonary cell cultures. Toxicol Sci. 2003;72(1):92–102.
You X, Cao X, Zhang X, Guo J, Sun W. Unraveling individual and combined toxicity of nano/microplastics and ciprofloxacin to Synechocystis sp. at the cellular and molecular levels. Environ Int. 2021;157:106842.
Zheng H, Wang J, Wei X, Chang L, Liu S. Proinflammatory properties and lipid disturbance of polystyrene microplastics in the livers of mice with acute colitis. Sci Total Environ. 2021;750:143085.
Zhu X, Munno K, Grbic J, Werbowski LM, Bikker J, Ho A, et al. Holistic assessment of microplastics and other anthropogenic microdebris in an Urban Bay sheds light on their sources and fate. ACS EST Water. 2021;1(6):1401–10.
Ziajahromi S, Kumar A, Neale PA, Leusch FDL. Impact of microplastic beads and fibers on Waterflea (Ceriodaphnia dubia) survival, growth, and reproduction: implications of single and mixture exposures. Environ Sci Technol. 2017;51(22):13397–406.
Zimmermann L, Bartosova Z, Braun K, Oehlmann J, Völker C, Wagner M. Plastic products leach chemicals that induce in vitro toxicity under realistic use conditions. Environ Sci Technol. 2021;55(17):11814–23.
Zimmermann L, Göttlich S, Oehlmann J, Wagner M, Völker C. What are the drivers of microplastic toxicity? Comparing the toxicity of plastic chemicals and particles to Daphnia magna. Environ Pollut. 2020;267:115392.
California Ocean protection act. Public Resources Code Sect 35635 2018.
California safe drinking water act. Health and Safety Code Sect 116376 2018.
The authors acknowledge all participants of the California Health Effects Workshop for their contributions towards conceptualizing these recommendations for the advancement of microplastics scientific research.
In keeping with research integrity principles, all SCCWRP workshop articles co-authored by Dr. Steve Weisberg, Dr. Albert Koelmans, and other Microplastics and Nanoplastics editors were handled by independent editors of the journal.
Funding for this project was provided by the California State Water Resources Control Board.
The authors L.M.T.H., S.C., A.C.M., E.M., and S.B.W. declare having no known competing financial interests or professional relationships that could have appeared to influence the work reported in this paper.
The following authors declare financial interests/professional relationships which may be considered as potential competing interests:
- H.B. is actively involved in research on the safety of nano and microplastics currently in two projects: Momentum (funded by the Dutch research organization ZonMW and Health Holland) and Plasticheal (EU H2020).
- S.M.B. reports a relationship with Ocean Science Trust that includes consulting or advisory and acknowledges funding from the National Science Foundation under grant agreement No. 1935028.
- M.C. acknowledges financial support from the MICRO-OPT project, Norwegian Retailers Fund (Handles Miljøfund, HMF).
- L.H. acknowledges funding from Environment and Climate Change Canada.
- C.M.R. reports a relationship with Ocean Conservancy as a Scientific Advisor.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Thornton Hampton, L.M., Bouwmeester, H., Brander, S.M. et al. Research recommendations to better understand the potential health impacts of microplastics to humans and aquatic ecosystems. Micropl.&Nanopl. 2, 18 (2022). https://doi.org/10.1186/s43591-022-00038-y
- Research recommendations
- Hazard characterization
- Aquatic organisms
- Human health
- Environmental management